Stay updated on DETERMINE-preserved: Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.

Latest updates to the DETERMINE-preserved: Dapagliflozin Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe DETERMINE-preserved study record is displayed with details on dapagliflozin versus placebo, participant criteria, study measures, locations, results, and linked study documents. Previously, the page showed a 403 Forbidden error.SummaryDifference86%

- Check15 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedA new Revision: v3.7.0 tag appears. Several study documents and links were removed from the page, indicating a revision of the available materials rather than updates to core content.SummaryDifference17%

Stay in the know with updates to DETERMINE-preserved: Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.